PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence and AOU Careggi, Florence, Italy. amvannucchi@unifi.it.\', \'Center Research Innovation of Myeloproliferative Neoplasms (CRIMM), SOD Hematology, University of Florence and AOU Careggi, Florence, Italy.\', \'Internal Medicine Unit 2, AOU Careggi, Florence, Italy.\', \'Internal Medicine Unit 1, AOU Careggi, Florence, Italy.\', \'Internal Medicine Unit 3, AOU Careggi, Florence, Italy.\', \'Intermediate Care Unit COVID-19, AOU Careggi, Florence, Italy.\', \'Infectious and Tropical Diseases Unit, AOU Careggi, Florence, Italy.\', \'Department of Clinical and Experimental Medicine, University of Florence, Florence, Italy.\', \'Cytometry and Immunotherapy Diagnostic Center (CDCI), AOU Careggi, Florence, Italy.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1038/s41375-020-01018-y
?:hasPublicationType
?:journal
  • Leukemia
is ?:pmid of
?:pmid
?:pmid
  • 32814839
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.131
?:rankingScore_hIndex
  • 168
is ?:relation_isRelatedTo_publication of
?:title
  • Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/32814839>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/32814839>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all